한글목차

솔리리스 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 20억 3,044만 달러에서 2026년에는 21억 9,190만 달러에 이르고, CAGR 8.0%로 성장할 전망입니다. 지난 수년간의 성장은 희귀질환의 미충족 수요, PNH 및 AHUS에서의 임상적 성공, 희귀질환 치료제 규제 혜택, 환자 생존율 개선, 치료 옵션이 제한적인 상황 등에 기인하는 것으로 보입니다.

솔리리스 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 29억 4,158만 달러에 이르고, CAGR은 7.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 보체 관련 질환에 대한 적용 확대, 희귀질환에 대한 인식 개선, 유전자 진단의 성장, 희귀질환 치료제에 대한 헬스케어 자금 증가, 장기 치료 지속 지원 프로그램 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 보체 억제 요법의 도입 증가, 초희귀질환에 대한 관심 증가, 장기 생물학적 치료제의 사용 확대, 희귀질환에 대한 유전자 검사 증가, 고부가가치 희귀의약품 시장의 성장 등을 들 수 있습니다.

향후 몇 년 동안 희귀혈액질환의 유병률 증가가 솔리리스 시장의 성장을 견인할 것으로 예측됩니다. 희귀혈액질환은 혈우병, 겸상적혈구증, 지중해빈혈 등 혈액의 생성, 구성성분, 응고에 영향을 미치는 희귀질환군입니다. 이러한 질환의 유병률 증가는 진단 방법의 개선, 인식 증가, 유전적 및 환경적 요인에 기인합니다. 솔리리스는 보체 단백질 C5를 억제하여 희귀혈액질환 환자에서 과도한 보체 활성화를 방지하는 작용을 합니다. 이를 통해 용혈이나 장기 손상과 같은 심각한 합병증 위험을 줄이고, 전반적인 질병 관리와 환자 예후를 개선할 수 있습니다. 예를 들어, 2024년 5월 영국 국민보건서비스(NHS)의 보고에 따르면, 영국에서는 약 17,000명이 유전성 혈액질환인 겸상적혈구증에 걸렸으며, 매년 약 250건의 새로운 사례가 진단되고 있다고 합니다. 이러한 희귀혈액질환의 유병률 증가가 솔리리스 시장의 성장을 견인하고 있습니다.

또한, 희귀질환 연구에 대한 투자 증가도 솔리리스 시장의 성장을 견인할 것으로 예측됩니다. 희귀질환 연구에 대한 투자가 급증하는 배경에는 미충족 수요에 대한 인식 증가, 유전체 과학의 발전, 환자 예후를 개선할 수 있는 획기적인 치료법의 가능성 등이 있습니다. 이러한 투자는 치료법이 충분하지 않은 질병에 대한 지식을 확장하고 효과적인 치료법에 대한 수요 증가로 이어져 솔리리스에 힘을 실어줄 수 있을 것입니다. 예를 들어, 2023년 7월 영국 보건사회부는 바이오메디컬 연구센터에 8억 3,420만 달러(7억 9,000만 파운드), 영국 희귀질환 연구 플랫폼에 1,506만 달러(1,200만 파운드), NIHR 바이오 리소스에 5,020만 달러(4, 000만 파운드)를 지원했습니다. 000만 파운드)를 기부했습니다. NIHR 바이오리소스는 50여종의 희귀질환에 대한 유전적 데이터와 임상적 특징을 연결하여 진단 및 치료법 개발의 향상을 도모하고 있습니다. 이러한 희귀질환 연구에 대한 투자 확대가 솔리리스 시장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 시장 규제 상황과 투자환경

제29장 경쟁 구도와 기업 개요

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 시장 잠재력이 높은 국가, 부문, 전략

제33장 부록

영문목차

Soliris (Eculizumab) is a monoclonal antibody developed by Alexion Pharmaceuticals that inhibits the complement protein C5, helping to reduce inflammation and tissue damage caused by an overactive immune system. It is primarily indicated for rare diseases, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG).

The main forms of Soliris include plasma exchange and plasma infusion. Plasma exchange is a procedure that removes and replaces a patient's plasma to treat conditions such as autoimmune and blood disorders. Soliris is used for applications in PNH and aHUS and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have influenced the soliris market by increasing costs associated with monoclonal antibody production inputs, infusion delivery systems, and cold chain logistics. These impacts are particularly evident in regions reliant on imported orphan biologics such as asia pacific and parts of europe. Hospital procurement costs have risen, affecting reimbursement negotiations. However, tariffs have encouraged localized biologics manufacturing investments. This supports long term access and supply continuity for rare disease treatments.

The soliris market research report is one of a series of new reports from The Business Research Company that provides soliris market statistics, including soliris industry global market size, regional shares, competitors with a soliris market share, detailed soliris market segments, market trends and opportunities, and any further data you may need to thrive in the soliris industry. This soliris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The soliris market size has grown strongly in recent years. It will grow from $2030.44 million in 2025 to $2191.9 million in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to unmet needs in rare diseases, clinical success in pnh and ahus, regulatory orphan drug incentives, improved patient survival outcomes, limited therapeutic alternatives.

The soliris market size is expected to see strong growth in the next few years. It will grow to $2941.58 million in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to expansion into additional complement mediated diseases, rising rare disease awareness, growth in genetic diagnostics, increased healthcare funding for orphan drugs, long term therapy adherence programs. Major trends in the forecast period include rising adoption of complement inhibitor therapies, growing focus on ultra rare diseases, expansion of long term biologic treatment use, increased genetic testing for rare disorders, high value orphan drug market growth.

The rising prevalence of rare blood disorders is expected to drive the growth of the Soliris market in the coming years. Rare blood disorders are uncommon conditions that affect the blood's production, components, or clotting, including hemophilia, sickle cell anemia, and thalassemia. The increasing prevalence of these disorders is attributed to better diagnostic methods, heightened awareness, and genetic and environmental factors. Soliris works by inhibiting the complement protein C5, helping patients with rare blood disorders by preventing excessive complement activation, which reduces the risk of severe complications such as hemolysis and organ damage, thereby improving overall disease management and patient outcomes. For example, in May 2024, the National Health Service (NHS) England reported that approximately 17,000 people in England are living with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. As a result, the growing prevalence of rare blood disorders is driving the Soliris market.

The increasing investment in rare disease research is also expected to boost the growth of the Soliris market. The surge in funding for rare disease research is driven by the growing recognition of unmet medical needs, advances in genomics, and the potential for breakthrough therapies that improve patient outcomes. Such investment supports Soliris by expanding knowledge of underserved conditions, leading to greater demand for effective treatments. For example, in July 2023, the UK Department of Health and Social Care provided significant funding, including USD 834.2 million (£790 million) for Biomedical Research Centers, USD 15.06 million (£12 million) for the UK Rare Disease Research Platform, and USD 50.2 million (£40 million) for the NIHR BioResource, which connects genetic data to clinical traits across 50 rare diseases to enhance diagnostics and treatment development. Consequently, the growing investment in rare disease research is driving the Soliris market.

A key trend in the Soliris market is the focus on developing biologic therapies for neuromyelitis optica spectrum disorder (NMOSD) to improve treatment options for rare blood disorders. This represents a notable advancement in managing NMOSD, a rare and debilitating autoimmune disease of the central nervous system, by offering an effective therapy that reduces relapses and prevents further neurological damage. For instance, in October 2023, AstraZeneca PLC, a UK-based pharmaceutical company, obtained approval for Soliris (eculizumab) from China's National Medical Products Administration (NMPA) to treat adult patients with NMOSD who are positive for anti-aquaporin-4 (AQP4) antibodies (Ab+). This approval made Soliris the first and only complement inhibitor authorized for NMOSD treatment in China.

Major companies operating in the soliris market are Pfizer

North America was the largest region in the Soliris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the soliris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the soliris market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

The soliris market consists of sales of soliris (eculizumab) 300 mg/30 mL vial, soliris (eculizumab) injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Soliris Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses soliris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for soliris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The soliris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Plasma Exchange; Plasma Infusion
• 2) By Application: Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (AHUS)
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: Pfizer
• Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Soliris Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Soliris Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Soliris Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Soliris Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Complement Inhibitor Therapies
  • 4.2.2 Growing Focus On Ultra Rare Diseases
  • 4.2.3 Expansion Of Long Term Biologic Treatment Use
  • 4.2.4 Increased Genetic Testing For Rare Disorders
  • 4.2.5 High Value Orphan Drug Market Growth

5. Soliris Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Rare Disease Treatment Centers
• 5.4 Specialty Pharmacies
• 5.5 Academic Research Hospitals

6. Soliris Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Soliris Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Soliris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Soliris Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Soliris Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Soliris Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Soliris Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Soliris Market Segmentation

• 9.1. Global Soliris Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Plasma Exchange, Plasma Infusion
• 9.2. Global Soliris Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (AHUS)
• 9.3. Global Soliris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

10. Soliris Market Regional And Country Analysis

• 10.1. Global Soliris Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Soliris Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Soliris Market

• 11.1. Asia-Pacific Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Soliris Market

• 12.1. China Soliris Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Soliris Market

• 13.1. India Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Soliris Market

• 14.1. Japan Soliris Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Soliris Market

• 15.1. Australia Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Soliris Market

• 16.1. South Korea Soliris Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 16.2. South Korea Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Soliris Market

• 17.1. Western Europe Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. Western Europe Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Soliris Market

• 18.1. UK Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Soliris Market

• 19.1. Germany Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Soliris Market

• 20.1. France Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Soliris Market

• 21.1. Eastern Europe Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Eastern Europe Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Soliris Market

• 22.1. North America Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 22.2. North America Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Soliris Market

• 23.1. USA Soliris Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 23.2. USA Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Soliris Market

• 24.1. Canada Soliris Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 24.2. Canada Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Soliris Market

• 25.1. South America Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 25.2. South America Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Soliris Market

• 26.1. Middle East Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Middle East Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Soliris Market

• 27.1. Africa Soliris Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Africa Soliris Market, Segmentation By Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Soliris Market Regulatory and Investment Landscape

29. Soliris Market Competitive Landscape And Company Profiles

• 29.1. Soliris Market Competitive Landscape And Market Share 2024
  • 29.1.1. Top 10 Companies (Ranked by revenue/share)
• 29.2. Soliris Market - Company Scoring Matrix
  • 29.2.1. Market Revenues
  • 29.2.2. Product Innovation Score
  • 29.2.3. Brand Recognition
• 29.3. Soliris Market Company Profiles
  • 29.3.1. Pfizer Overview, Products and Services, Strategy and Financial Analysis

30. Global Soliris Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Soliris Market

32. Soliris Market High Potential Countries, Segments and Strategies

• 32.1 Soliris Market In 2030 - Countries Offering Most New Opportunities
• 32.2 Soliris Market In 2030 - Segments Offering Most New Opportunities
• 32.3 Soliris Market In 2030 - Growth Strategies
  • 32.3.1 Market Trend Based Strategies
  • 32.3.2 Competitor Strategies

33. Appendix

• 33.1. Abbreviations
• 33.2. Currencies
• 33.3. Historic And Forecast Inflation Rates
• 33.4. Research Inquiries
• 33.5. The Business Research Company
• 33.6. Copyright And Disclaimer